• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.06% Nasdaq Up 0.42%

    Pharmacyclics Inc. (PCYC)

    -NasdaqGS
    217.82 Down 2.40(1.09%) 4:00PM EST
    |After Hours : 217.40 Down 0.42 (0.19%) 6:18PM EST
    Add to Portfolio
    Prev Close:220.22
    Open:218.44
    Bid:216.50 x 500
    Ask:217.84 x 100
    1y Target Est:185.21
    Beta:0.76
    Next Earnings Date:N/A
    Day's Range:211.59 - 220.15
    52wk Range:82.51 - 231.09
    Volume:3,254,077
    Avg Vol (3m):1,031,510
    Market Cap:16.56B
    P/E (ttm):196.23
    EPS (ttm):1.11
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    PCYCDown 1.09%16.56B
    CTICDown 0.21%345.43M
    MRKUp 0.80%168.09B

    Key Statistics

    Forward P/E (1 yr):54.32
    P/S (ttm):22.94
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.73
    Quarterly EPS Est (Mar-15) :0.13
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):1,885.44

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Pharmacyclics, Inc., a biopharmaceutical company, designs, develops, and commercializes small-molecule drugs for the treatment of cancer and immune mediated diseases in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback